/
/
/

Onesource Specialty Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹449 Cr₹428 Cr₹290 Cr₹376 Cr₹327 Cr₹426 Cr₹393 Cr₹334 Cr₹292 Cr₹73 Cr₹56 Cr₹34 Cr
₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹9 L
₹453 Cr₹430 Cr₹295 Cr₹379 Cr₹333 Cr₹429 Cr₹399 Cr₹338 Cr₹296 Cr₹76 Cr₹57 Cr₹34 Cr
₹397 Cr₹408 Cr₹343 Cr₹339 Cr₹307 Cr₹312 Cr₹319 Cr₹325 Cr₹296 Cr₹95 Cr₹86 Cr₹91 Cr
₹127 Cr₹94 Cr₹22 Cr₹110 Cr₹94 Cr₹185 Cr₹149 Cr₹82 Cr₹68 Cr-₹16 L-₹9 Cr-₹38 Cr
₹31 Cr₹23 Cr₹38 Cr₹34 Cr₹27 Cr₹33 Cr₹46 Cr₹45 Cr₹42 Cr₹20 Cr₹26 Cr₹25 Cr
₹20 Cr-₹29 L-₹93 Cr₹6 Cr-₹4 Cr₹84 Cr-₹67 Cr-₹37 Cr-₹47 Cr-₹40 Cr-₹161 Cr-₹87 Cr
₹25 Cr₹5 Cr-₹89 Cr₹10 Cr-₹19 L₹99 Cr-₹69 Cr-₹42 Cr-₹6 Cr-₹40 Cr-₹130 Cr-₹114 Cr

Share Price Live Stats

Open (₹)1,585.00
Volume (₹)1.03 L
High (₹)1,596.30
Upper Circuit1,890.80
Low (₹)1,526.00
Lower Circuit1,260.60
Prev Close1,575.70
52W High (₹)1,925.00
Price1,535.00
52W Low (₹)1,057.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)18046.10 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.22
Price to Book2.90
Book Value508.17
EPS (TTM)-4.24
Face Value1.00
ROE (%)-1.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ONESOURCENSE
LTP
1W Low
1W High
Market cap (₹)
1898.9-21.1 (-1.10%)
1895
1984.80
4,56,833Cr
9121-118 (-1.28%)
9087
9467
2,45,426Cr
4845-205 (-4.06%)
4823
5066
1,87,320Cr
1124.2-66.8 (-5.61%)
1123
1187
1,13,217Cr
1384-39.5 (-2.77%)
1375.50
1426.10
1,12,212Cr
1842.3-96.2 (-4.96%)
1811.70
1949
1,01,155Cr
2107.8-63.7 (-2.93%)
2100.60
2192
97,626Cr
2327.1-55.8 (-2.34%)
2317
2419.20
96,859Cr
1155.7-22.3 (-1.89%)
1154
1179.90
96,406Cr
1652+6.7 (0.41%)
1622.60
1717
93,614Cr
1535+2.8 (0.18%)
1504.10
1596.60
18,046Cr

Key Highlights of Onesource Specialty Pharma Ltd’s P&L

In 2026-03-31, Onesource Specialty Pharma Ltd reported total revenue of ₹1468.05Cr, compared with ₹1465.04Cr in 2025-03-31, reflecting Onesource Specialty Pharma Ltd turnover.

Depreciation was ₹279.09Cr and finance costs were ₹122.19Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹91.96Cr in 2026-03-31 as compared to ₹-₹67.07Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹73.8Cr in 2026-03-31 compared with ₹-₹17.97Cr in 2025-03-31.

Earnings per share (EPS) were ₹-6.44 in 2026-03-31, compared with ₹-1.57 in 2025-03-31.